Qube Research & Technologies (QRT)’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
14,500
+13,800
+1,971% +$2.05M ﹤0.01% 2066
2026
Q1
$103K Sell
700
-10,300
-94% -$1.59M ﹤0.01% 3062
2025
Q4
$1.7M Buy
11,000
+8,500
+340% +$1.27M ﹤0.01% 2323
2025
Q3
$348K Buy
2,500
+1,000
+67% +$135K ﹤0.01% 2809
2025
Q2
$202K Buy
+1,500
New +$203K ﹤0.01% 2909
2024
Q2
Sell
-51,600
Closed -$7.62M 4840
2024
Q1
$7.62M Buy
+51,600
New +$7.4M 0.01% 994

Other funds holding XLV

Qube Research & Technologies (QRT)'s XLV Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 23% in Q2 2026, selling an estimated $19.4M and leaving 434,744 shares worth $69M. The position accounts for 0.06% of the portfolio, ranked #393.

Qube Research & Technologies (QRT) first reported a position in XLV in Q4 2019 and has held it in 23 quarters since. The position peaked at $171M in Q2 2025. 1,863 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Qube Research & Technologies (QRT) held 434,744 shares of State Street Health Care Select Sector SPDR ETF worth $69M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 130,466 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $19.4M.
  • State Street Health Care Select Sector SPDR ETF made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #393 holding.
  • Qube Research & Technologies (QRT) first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and has held it in 23 quarters since.
  • Qube Research & Technologies (QRT)'s State Street Health Care Select Sector SPDR ETF position peaked at $171M in Q2 2025.
  • 1,863 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.